Tenecteplase for Acute Ischemic Stroke Within 4.5 to 6 Hours of Onset (EXIT-BT2)
Clinical trial NCT06010628 · RECRUITING
Trial details
- NCT number
- NCT06010628
- Sponsor
- General Hospital of Shenyang Military Region
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-01
- Primary completion
- 2026-12-15
- Enrollment
- 1440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.